Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer

• Autori principali: Kuo-Chang Wen (Autore), Pi-Lin Sung (Autore), Alexander T. H. Wu (Autore), Ping-Chieh Chou (Autore), Jun-Hung Lin (Autore), Chi-Ying F. Huang (Autore), Sai-Ching J. Yeung (Autore), Mong-Hong Lee (Autore)
• Natura: Libro
• Pubblicazione: BMC, 2020-08-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Abstract Background Ovarian cancer is the leading cause of cancer-related death among women. Complete cytoreductive surgery followed by platinum-taxene chemotherapy has been the gold standard for a long time. Various compounds have been assessed in an attempt to combine them with conventional chemot...